September 25, 2018
Rose
The pharmaceutical industry has been trying to get Congress to change a law passed earlier this year that requires drug manufacturers to provide deeper discounts to Medicare beneficiaries whose spending on prescription drugs falls within a range called the coverage gap. The fast-moving, massive opioid package seemed like a perfect opportunity for the drug companies, but the move is sparking outrage from some lawmakers and consumer advocates.
from Kaiser Health News https://ift.tt/2Ig8Llk
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment